- Home
- NMTC vs RADX Comparison
NMTC vs RADX Comparison
Compare NMTC & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMTC
- RADX
- Stock Information
- Founded
- NMTC 2009
- RADX 2021
- Country
- NMTC United States
- RADX Australia
- Employees
- NMTC N/A
- RADX N/A
- Industry
- NMTC Medical/Dental Instruments
- RADX
- Sector
- NMTC Health Care
- RADX
- Exchange
- NMTC Nasdaq
- RADX NYSE
- Market Cap
- NMTC 33.8M
- RADX 32.5M
- IPO Year
- NMTC N/A
- RADX N/A
- Fundamental
- Price
- NMTC $0.72
- RADX $4.30
- Analyst Decision
- NMTC Strong Buy
- RADX Strong Buy
- Analyst Count
- NMTC 1
- RADX 2
- Target Price
- NMTC $1.45
- RADX $13.50
- AVG Volume (30 Days)
- NMTC 179.3K
- RADX 18.3K
- Earning Date
- NMTC 08-13-2025
- RADX 02-26-2025
- Dividend Yield
- NMTC N/A
- RADX N/A
- EPS Growth
- NMTC N/A
- RADX N/A
- EPS
- NMTC N/A
- RADX N/A
- Revenue
- NMTC $5,758,777.00
- RADX $204,609.00
- Revenue This Year
- NMTC $157.28
- RADX N/A
- Revenue Next Year
- NMTC $41.79
- RADX N/A
- P/E Ratio
- NMTC N/A
- RADX N/A
- Revenue Growth
- NMTC 54.53
- RADX N/A
- 52 Week Low
- NMTC $0.40
- RADX $3.50
- 52 Week High
- NMTC $1.39
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- NMTC 57.22
- RADX N/A
- Support Level
- NMTC $0.69
- RADX N/A
- Resistance Level
- NMTC $0.77
- RADX N/A
- Average True Range (ATR)
- NMTC 0.04
- RADX 0.00
- MACD
- NMTC -0.00
- RADX 0.00
- Stochastic Oscillator
- NMTC 53.50
- RADX 0.00
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.